News
Current Recommendations of the Expert Panel on the Management of von Willebrand Disease
Von Willebrand disease (vWD) is a common congenital bleeding disorder. The care of patients with vWD involves significant variability due to bleeding manifestations and treatment options. The new recommendations from 2021 regarding the care of people with vWD are evidence-based and supported by the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation USA (NHF), and the World Federation of Hemophilia (WFH). We bring you a concise summary of the key points.
How and with What the National Registry of Primary Immunodeficiencies Benefits Specialists and Patients
Update of the Blue Book: What's New in the Treatment of Metastatic NSCLC with an ALK Gene Mutation?
Brain Metastases Are Not an Absolute Contraindication for Antiplatelet Therapy
Complete remission of ALK-positive lung cancer in a patient after multiple lines of targeted therapy – a case study
How Do Vaccinated MS Patients Fare with COVID-19 Antibodies?
When Teriflunomide and Interferon Join Forces
Fixed Combination of Tiotropium/Olodaterol in SMI Inhaler and Its Benefits in COPD Treatment
Protection of Ovarian Function During Breast Cancer Treatment
New Antidiabetic Drugs in Cardiovascular Prevention in International Recommendations
Conferences
News from the world of medicine
All conferences
Popular this week
- Where did COVID come from? Are infected animals or a lab leak to blame for the pandemic?
- Target blood pressure values in heart failure
- BENIGN DERMATOSIS OF PENIS
- Hypercalcemia may be the first sign of multiple myeloma, but not only that
- Could Artificial Intelligence Help with Emergency Department Triage in the Future?